Literature DB >> 7747097

Serological and clinical characteristics of measles vaccine failure in Japan.

Y Hidaka1, T Aoki, H Akeda, C Miyazaki, K Ueda.   

Abstract

In 1991, in Fukuoka, Japan, a measles outbreak occurred in which we observed 15 cases of measles vaccine failure (MVF). We examined these patients both clinically and serologically. Seven of them, with a response pattern of an early rise in and attainment of a high hemagglutination inhibition (HI) antibody titre, were considered to be secondary vaccine failures (EH group). Eight others showed a normal (relatively late rise and low titre) HI antibody response pattern and were considered to be primary vaccine failures (LL group). In both MVF groups, measles-specific IgM antibody was detected by enzyme immunoassay. The EH group had a milder rash than did the LL group and unvaccinated controls. We believe they had an immunological memory that modified the clinical manifestations of measles. Two cases of encephalitis were observed in the EH group; both patients recovered without sequelae. These data suggest that the mere presence or absence of IgM antibody is not sufficient to differentiate primary from secondary MVFs. A two-dose measles vaccination scheme should be recommended to secure a booster effect, because immunity is waning in the population in which the measles vaccination rate is not high enough and in which natural measles still exists.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7747097     DOI: 10.3109/00365549409008642

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.

Authors:  Janet L Fox; Stuart L Hazell; Leslie H Tobler; Michael P Busch
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.

Authors:  M Narita; S Yamada; Y Matsuzono; O Itakura; T Togashi; H Kikuta
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.

Authors:  Cláudio S Pannuti; Ricardo José Morello; José Cássio de Moraes; Suely Pires Curti; Ana Maria S Afonso; Maria Cláudia Corrêa Camargo; Vanda A U F de Souza
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.